Advances in the psychosocial treatment of anxiety disorders: Implications for national health care

Archives of General Psychiatry

Volumn 53, Issue 8, 1996, Pages 727-735

  Barlow, David H ^a   Lehman, Cassandra L ^a  

^a BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGORAPHOBIA; ANXIETY NEUROSIS; ARTICLE; HEALTH CARE POLICY; HEALTH CARE SYSTEM; MENTAL HEALTH CARE; MENTAL HEALTH SERVICE; OBSESSION; PANIC; PHOBIA; POSTTRAUMATIC STRESS DISORDER; SOCIAL PSYCHOLOGY;

EID: 0029756663     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.1996.01830080079013     Document Type: Article

References (117)

1. Agras S, Leitenberg H, Barlow DH. Social reinforcement in the modification of agoraphobia. Arch Gen Psychiatry. 1968;19:423-427.
2. Marks IM. Fears and Phobias. London, England: Heineman; 1969.
3. Barlow DH. Anxiety and Its Disorders: The Nature and Treatment of Anxiety and Panic. New York, NY: Guilford Press: 1988.
4. Jansson L, Öst L-G. Behavioral treatments for agoraphobia: an evaluative review. Clin Psychol Rev. 1982;2:311-336.
5. Mavissakalian M. Antidepressant medications for panic disorder. In: Mavissakalian M, Prien R, eds. Long-Term Treatments of Anxiety Disorders. Washington, DC: American Psychiatric Press Inc; 1996:265-284.
6. Burns LE, Thorpe GL, Cavallaro LA. Agoraphobia eight years after behavioral treatment. Behav Ther. 1986;17:580-591.
7. Cohen SD, Monteiro W, Marks IM. Two-year follow-up of agoraphobics after exposure and imipramine. Br J Psychiatry. 1984;144:276-281.
8. Fava GA, Zielezny M, Savron G, Grandi S. Long-term effects of behavioural treatment for panic disorder with agoraphobia. Br J Psychiatry. 1995;166:87-92.
9. Jansson L, Jerremalm A, Öst L-G. Follow-up of agoraphobia patients treated with exposure in vivo or applied relaxation. Br J Psychiatry. 1986;149:486-490.
10. Munby J, Johnson DW. Agoraphobia: the long-term follow-up of behavioral treatment. Br J Psychiatry. 1980;137:418-427.
11. Klein DF. Importance of psychiatric diagnosis in prediction of clinical drug effects. Arch Gen Psychiatry. 1967;16:118-126.
12. Mendel JGC, Klein DF. Anxiety attacks with subsequent agoraphobia. Compt Psychiatry. 1969;10:190-195.
13. Barlow DH, Craske MG, Cerny JA, Klosko JS. Behavioral treatment of panic disorder. Behav Ther. 1989;20:261-282.
14. Craske MG, Brown TA, Barlow DH. Behavioral treatment of panic: a two-year follow-up. Behav Ther. 1991;22:289-304.
15. Clark DM, Salkovskis PM, Hackmann A, Middleton H, Anastasiades P, Gelder M. A comparison of cognitive therapy, applied relaxation and imipramine in the treatment of panic disorder. Br J Psychiatry. 1994;164:759-769.
16. Klosko JS, Barlow DH, Tassinari R, Cerny JA. A comparison of alprazolam and behavior therapy in treatment of panic disorder. J Consult Clin Psychol. 1990;58:77-84.
17. Newman CF, Beck JS, Beck AT. Efficacy of cognitive therapy in reducing panic attacks and medication. Presented at the 24th Annual Meeting of the Association for Advancement of Behavior Therapy; November 1990: San Francisco, Calif.
18. Côté G, Gauthier J, Laberge B. The impact of medication use on the efficacy of cognitive-behavioral therapy for panic disorder. Presented at the 26th Annual Meeting of the Association for Advancement of Behavior Therapy; November 1992; Boston, Mass.
19. Beck AT, Sokol L, Clark DA, Berchick R, Wright F. A crossover study of focused cognitive therapy for panic disorder. Am J Psychiatry. 1992;149:778-783.
20. Black DW, Wesner R, Bowers W, Gabel J. A comparison of fluvoxamine, cognitive therapy, and placebo in the treatment of panic disorder. Arch Gen Psychiatry. 1993;50:44-50.
21. Margraf J, Schneider S. Outcome and active ingredients of cognitive-behavioral treatments for panic disorder. Presented at the 25th Annual Meeting of the Association for Advancement of Behavior Therapy; November 1991; New York, NY.
22. Öst L-G, Westling BE, Hellstrom, K. Applied relaxation, exposure in vivo and cognitive methods in the treatment of panic disorder with agoraphobia. Behav Res Ther. 1993;31:383.
23. Telch MJ, Lucas JA, Schmidt NB, Hanna HH, Jaimez LaNae T, Lucas RA. Group cognitive-behavioral treatment of panic disorder. Behav Res Ther. 1993; 31:279-287.
24. Craske MG, Maidenberg E, Bystritsky A. Brief cognitive-behavioral versus non- directive therapy for panic disorder. J Behav Ther Exper Psychiatry. 1995; 26:113-120.
25. Shear MK, Pilkonis PA, Cloitre M, Leon AC. Cognitive behavioral treatment compared with nonprescriptive treatment of panic disorder. Arch Gen Psychiatry. 1994;51:395-401.
26. Brown TA, Barlow DH. Long-term outcome in cognitive behavioral treatment of panic disorder. J Consult Clin Psychol. 1995;63:754-765.
27. Brown TA, Antony MM, Barlow DH. Diagnostic comorbidity in panic disorder. J Consult Clin Psychol. 1995;63:408-418.
28. Michelson L, Marchione K, Greenwald M. Cognitive-behavioral treatments of agoraphobia. Presented at the 23rd Annual Meeting of the Association for the Advancement of Behavior Therapy; November 1989; Washington, DC.
29. van den Hout M, Arntz A, Hoekstra R. Exposure reduced agoraphobia but not panic, and cognitive therapy reduced panic but not agoraphobia. Behav Res Ther. 1994;52:447-449.
30. Marks IM, Swinson RP, Basoglu M, Kuch K, Noshirvani H, O'Sullivan G, Lelliott PT, Kirby M, McNamee G, Sengun S, Wickwire K. Alprazolam and exposure alone and combined in panic disorder with agoraphobia: a controlled study in London and Toronto. Br J Psychiatry. 1993;162:776-787.
31. Mavissakalian M. Combined behavioral therapy and pharmacotherapy of agoraphobia. J Psychiatr Res. 1993;27:179-191.
32. Otto MW, Pollack MH, Sachs GS, Reiter SR, Meltzer-Brody S, Rosenbaum JF. Discontinuation of benzodiazepine treatment Am J Psychiatry. 1993;150: 1485-1490.
33. Spiegel DA, Bruce TJ, Gregg SF, Nuzzarello A. Does cognitive behavior therapy assist slow-taper alprazolam discontinuation in panic disorder? Am J Psychiatry. 1994;151:876-881.
34. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised. Washington, DC: American Psychiatric Association; 1987.
35. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Press; 1994.
36. Barlow DH, Blanchard EB, Vermilyea JA, Vermilyea BB, Di Nardo PA. Generalized anxiety and generalized anxiety disorder: description and reconceptualization. Am J Psychiatry. 1986;143:40-44.
37. Brown TA, Bariow DH, Liebowitz MR. The empirical basis of generalized anxiety disorder. Am J Psychiatry. 1994;15:1272-1280.
38. Rapee RM, Barlow DH. Chronic Anxiety: Generalized Anxiety Disorder and Mixed Anxiety-Depression. New York, NY: Guilford Publications Inc; 1991.
39. Zinbarg RE, Barlow DH, Liebowitz M, Street L, Broadhead E, Katon W, Roy-Byrne P, Lepine JP, Teherani M, Richard J, Brantley PJ, Kraemer H. The DSM-IV field trial for mixed-anxiety depression. Am J Psychiatry. 1994;151:1153-1162.
40. Barlow DH, Rapee RM, Brown TA. Behavioral treatment of generalized anxiety disorder. Behav Ther. 1992;23:551-570.
41. Blowers C, Cobb J, Mathews A. Generalized anxiety: a controlled treatment study. Behav Res Ther. 1987;25:493-502.
42. Borkovec TD, Mathews AM. Treatment of nonphobic anxiety disorders. J Consult Clin Psychol. 1988;56:877-884.
43. Durham RC, Turvey AA. Cognitive therapy vs behaviour therapy in the treatment of chronic generalized anxiety. Behav Res Ther. 1987;25:229-234.
44. Lindsay, WR, Gamsu CV, McLaughlin E, Hood EM, Espie CA. A controlled trial of treatments for generalized anxiety. Br J Clin Psychol. 1987;26:3-15.
45. Borkovec TD, Costello E. Efficacy of applied relaxation and cognitive-behavioral therapy in the treatment of generalized anxiety disorder. J Consult Clin Psychol. 1993;61:611-619.
46. Butler G, Fennell M, Robson P, Gelder M. Comparison of behavior therapy and cognitive behavior therapy in the treatment of generalized anxiety disorder. J Consult Clin Psychol. 1991;59:167-175.
47. Durham RC, Murphy T, Allan T, Richard K, Treliving LR, Fenton GW. Cognitive therapy, analytic psychotherapy and anxiety management training for generalised anxiety disorder. Br J Psychiatry. 1994;165:315-323.
48. Power J, Simpson RJ, Swanson V, Wallace LA, Feistner ATC, Sharp D. A controlled study of cognitive-behaviour therapy, diazepam and placebo alone and in combination for the treatment of generalized anxiety. J Anxiety Disord. 1990;4:267-292.
49. Borkovec TD, Whisman MA. Psychosocial treatment for generalized anxiety disorder. In: Mavissakalian M, Prien R, eds. Anxiety Disorders: Psychological and Pharmacological Treatments. Washington, DC: American Psychiatric Press Inc; 1996:171-199.
50. Barlow DH, Cohen AS, Waddell M, Vermilyea JA, Klosko JS, Blanchard EB, DiNardo PA. Panic and generalized anxiety disorders: nature and treatment. Behav Ther. 1984;15:431-449.
51. Borkovec TD, Mathews AM, Chambers A, Ebrahimi S, Lytle R, Nelson R. The effects of relaxation training with cognitive therapy or nondirective therapy and the role of relaxation-induced anxiety in the treatment of generalized anxiety. J Consult Clin Psychol. 1987;55:883-888.
52. Butler G, Cullington A, Hibbert G, Klimes I, Gelder M. Anxiety management for persistent generalized anxiety. Br J Psychiatry. 1987;151:535-542.
53. Power KG, Jerrom DW, Simpson RJ, Mitchell MJ, Swanson V. A controlled comparison of cognitive behavior therapy, diazepam and placebo in the management of generalized anxiety. Behav Psychother. 1989;17:1-14.
54. White J, Keenan M, Brooks N. Stress control. Behav Psychol. 1992;201:97-114.
55. Borkovec TD, Abel JL, Newman H. Effects of psychotherapy on comorbid conditions in generalized anxiety disorder. J Consult Clin Psychol. 1995;63:479-483.
56. Blown TA, O'Leary TA, Barlow DH. Cognitive-behavioral treatment of generalized anxiety disorder. In: Barlow DH, ed. Clinical Handbook of Psychological Disorders. 2nd ed. New York, NY: Guilford Publication Inc; 1993:137-188.
57. The Clomipramine Collaborative Study Group. Clomipramine in the treatment of patients with obsessive-compulsive disorder. Arch Gen Psychiatry. 1991; 48:730-738.
58. Rachman S, Hodgson R. Obsessions and Compulsions. Englewood Cliffs, NJ: Prentice Hall; 1980.
59. Meyer V. Modification of expectations in cases with obsessional rituals. Behav Res Ther. 1966;4:273-280.
60. Riggs DS, Foa EB. Obsessive compulsive disorder. In: Barlow DH, ed. Clinical Handbook of Psychological Disorders. 2nd ed. New York, NY: Guilford Press; 1993:189-239.
61. Salkovskis PM, Westbrook D. Behaviour therapy and obsessional ruminations: can failure be turned into success? Behav Res Ther. 1989;27:149-160.
62. Foa EB, Kozak MJ. Psychological treatment for obsessive-compulsive disorder. In: Mavissakalian M, Prien R, eds. Long-Term Treatments of Anxiety Disorders. Washington, DC: American Psychiatric Press Inc; 1996:285-309.
63. Meyer V, Levy R, Schnurer A. A behavioral treatment of obsessive-compulsive disorders. In: Beech HR, ed. Obsessional States. London, England: Methuen; 1974.
64. Catts S, McConaghy N. Ritual prevention in the treatment of obsessive-compulsive neurosis. Aust N Z J Psychiatry. 1975;9:37-41.
65. Marks IM, Hodgson R, Rachman S. Treatment of chronic obsessive-compulsive neurosis by in vivo exposure. Br J Psychiatry. 1975;127:349-364.
66. Boulougouris JC. Variables affecting the behavior modification of obsessive-compulsive patients treated by flooding. In: Boulougouris JC, Rabavilas AD, eds. The Treatment of Phobic and Obsessive-Compulsive Disorders. Oxford, England: Pergamon Press; 1977:73-84.
67. Foa EB, Goldstein A. Continuous exposure and complete response prevention of obsessive-compulsive neurosis. Behav Ther. 1978;9:821-829.
68. Emmelkamp PMG, Rabbie DM. Psychological treatment of obsessive-compulsive disorder. Biol Psychiatry. 1981:1095-1098.
69. Mawson D, Marks IM, Ramm L. Clomipramine and exposure for chronic obsessive-compulsive rituals, III: two year follow-up and further findings. Br J Psychiatry. 1982;140:11-18.
70. O'Sullivan G, Noshirvani H, Marks I, Monteiro W, Lelliott P. Six-year follow-up after exposure and Clomipramine therapy for obsessive-compulsive disorder. J Clin Psychiatry. 1991;52:150-155.
71. Bolton D, Collins S, Steinberg D. The treatment of obsessive-compulsive disorder in adolescence: a report of fifteen cases. Br J Psychiatry. 1983;142:456-464.
72. Foa EB, Grayson JB, Steketee GS, Doppelt HG, Turner RM, Latimer PR. Success and failure in the behavioral treatment of obsessive-compulsives. J Consult Clin Psychol. 1983;51:287-297.
73. Foa EB, Steketee G, Grayson JB, Turner RM, Latimer P. Deliberate exposure and blocking of obsessive-compulsive rituals: immediate and long-term effects. Behav Ther. 1984;15:450-472.
74. Hoogduin CAL, Hoogduin WA. The outpatient treatment of patients with an obsessional-compulsive disorder. Behav Res Ther. 1984;22:455-459.
75. Emmelkamp PMG, Hoekstra RJ, Visser S. The behavioral treatment of obsessive-compulsive disorder: prediction of outcome at 3.5 years follow-up. In: Pichot P, Brenner A, Wolf R, Thau K, eds. Psychiatry: The State of the Art. New York, NY: Plenum Press; 1985:4.
76. Kasvikas Y, Marks I. Clomipramine, self-exposure, and therapist-accompanied exposure in obsessive-compulsive ritualizers: two-year follow up. J Anxiety Disord. 1988;2:291-298.
77. Foa EB, Kozak MJ, Steketee GS, McCarty PR. Treatment of depressive and obsessive-compulsive symptoms in OCD by imipramine and behavior therapy. Br J Psychiatry. 1992;31:279-292.
78. Cottraux J, Mollard E, Bouvard M, Marks I, Sluys M, Nury AM, Douge R, Cialdella PH. A controlled study of fluvoxamine and exposure in obsessive-compulsive disorder. Int Clin Psychopharmacol. 1990;5:299-317.
79. Marks IM, Stern RS, Mawson D, Cobb J, McDonald R. Clomipramine and exposure for obsessive-compulsive rituals, I. Br J Psychiatry. 1980;136:1-25.
80. Marks IM, Lelliott P, Basoglu M, Noshirvami H, Monteiro W, Cohen D, Kasvikis Y. Clomipramine self-exposure, and therapist-aided exposure for obsessive-compulsive rituals. Br J Psychiatry. 1988;152:522-534.
81. Hiss H, Foa EB, Kozak MJ. Relapse prevention program for treatment of obsessive-compulsive disorder. J Consult Clin Psychol. 1994;4:801-808.
82. Marlatt GA, Gordon JR. Relapse Prevention: Maintenance Strategies in Addictive Behavior Changes. New York, NY: Guilford Publications Inc; 1985.
83. Foa EB, Liebowitz M. Recent findings on the efficacy of behavior therapy and clomipramine for obsessive-compulsive disorder. Presented at the Psychiatric Research Society Annual Meeting; February 1995; Park City, Utah.
84. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry. 1994;51:8-19.
85. Liebowitz MR, Gorman JM, Fyer AJ, Klein DF. Social phobia: review of a neglected anxiety disorder. Arch Gen Psychiatry. 1985;42:729-736.
86. Butler G, Cullington, A, Munby M, Amies P, Gelder M. Exposure and anxiety management in the treatment of social phobia. J Consult Clin Psychol. 1984; 52:642-650.
87. Mattick RP, Peters L. Treatment of severe social phobia. J Consult Clin Psychol. 1988;56:251-260.
88. Mattick RP, Peters L, Clarke JC. Exposure and cognitive restricting for social phobia: a controlled study. Behav Ther. 1989;20:3-23.
89. Heimberg RG, Dodge CS, Hope DA, Kennedy CR, Zollo L, Becker RE. Cognitive-behavioral group treatment of social phobia: comparison to a credible placebo control. Cognitive Ther Res. 1990;14:1-23.
90. Heimberg RG, Salzman DG, Holt CS, Blendell KA. Cognitive-behavioral group treatment for social phobia. Cognitive Ther Res. 1993;4,325-339.
91. Hope DA, Heimberg RG, Bruch MA. The importance of cognitive intervention in behavioral group therapy for social phobia. Presented at the Tenth National Conference on Phobias and Related Anxiety Disorders; March 1990; Bethesda, Md.
92. Gelernter CS, Uhde TW, Cimbolic P, Arnkoff DB, Vittone BJ, Tancer ME, Bartko JJ. Cognitive-behavioral and pharmacological treatments of social phobia: a controlled study. Arch Gen Psychiatry. 1991;48:938-945.
93. Lucas RA, Telch MJ. Group vs individual treatment of social phobia. Presented at the 27th Annual Meeting of the Association for Advancement of Behavior Therapy; November 1993; Atlanta, Ga.
94. Heimberg RG, Juster HR, Brown EJ, Holle C, Makris GS, Leung AW, Schneier FR, Gitow A, Liebowitz MR. Cognitive-behavioral versus pharmacological treatment of social phobia: posttreatment and follow-up effects. Presented at the 28th Annual Meeting of the Association for Advancement of Behavior Therapy; November 1994; San Diego, Calif.
95. Öst L-G, Sterner U. Applied tension, a specific behavioral method for treatment of blood phobia. Behav Res Ther. 1987;25:25-29.
96. Öst L-G, Lindahl I-L, Sterner U, Jerremalm A. Exposure in vivo vs applied relaxation in the treatment of blood phobia. Behav Res Ther. 1984;22:205-216.
97. Öst L-G, Sterner U, Lindahl IL. Physiological responses in blood phobia. Behav Res Ther. 1984;22:109-117.
98. Öst L-G, Sterner U, Fellenius J. Applied tension, applied relaxation, and the combination in the treatment of blood phobia. Behav Res Ther. 1989;27:109-121.
99. Öst L-G, Salkovskis PM, Hellström K. One-session therapist-directed exposure vs self-exposure in the treatment of spider phobia. Behav Ther. 1991; 22:407-422.
100. Öst L-G, Hellström K, Kaver A. One vs five sessions of exposure in the treatment of injection phobia. Behav Ther. 1992;23:263-282.
101. Keane TM, Fairbank JA, Caddell JM, Zimering RT. Implosive (flooding) therapy reduces symptoms of PTSD in Vietnam combat veterans. Behav Ther. 1989; 20:245-260.
102. Cooper NA, Clum GA. Imaginal flooding as a supplementary treatment for PTSD in combat veterans: a controlled study. Behav Ther. 1989;20:381-391.
103. Boudewyns PA, Hyer L. Physiological response to combat memories and preliminary treatment outcome in Vietnam veteran PTSD patients treated with direct therapeutic exposure. Behav Ther. 1990;21:63-87.
104. Foa EB, Rothbaum EO, Riggs D, Murdock T. Treatment of PTSD in rape victims: a comparison between cognitive-behavioral procedures and counseling. J Consult Clin Psychol. 1991;59:715-723.
105. Foa, EB. Psychopathology and treatment of PTSD in rape victims. Presented at the annual convention of the American Psychological Society; July 1, 1994; Washington, DC.
106. Resick PA, Schnicke MK. Cognitive processing therapy for sexual assult victims. J Consult Clin Psychol. 1992;60:748-756.
107. Foa EB, Hearst-Ikeda D, Perry KJ. Evaluation of a brief cognitive-behavioral program for the prevention of chronic PTSD in recent assault victims. J Consult Clin Psychol. 1995;63:948-955.
108. Calhoun KS, Resick PA. Post-traumatic stress disorder. In: Barlow DH, ed. Clinical Handbook of Psychological Disorders. 2nd ed. New York, NY: Guilford Publications Inc; 1993:48-98.
109. Breier A, Charney DS, Heninger GR. Agoraphobia with panic attacks: development, diagnostic stability, and course of illness. Arch Gen Psychiatry. 1986; 43:1029-1036.
110. Goisman RM, Rogers MP, Steketee GS, Warshaw MG, Cuneo P, Keller MB. Utilization of behavioral methods in a multi-center anxiety disorders study. J Clin Psychiatry. 1993;54:213-218.
111. Taylor CB, King R, Margraf J, Ehlers A, Telch M, Roth WT, Agras WS. Use of medication and in vivo exposure in volunteers for panic disorder research. Am J Psychiatry. 1989;146:1423-1426.
112. Ghosh A, Marks IM. Self-treatment of agoraphobia by exposure. Behav Ther. 1987;18:3-16.
113. Côté G, Gauthier JG, Laberge B, Cormier HJ, Plamondon J. Reduced therapist contact in the cognitive behavioral treatment of panic disorder. Behav Ther. 1994;25:123-145.
114. Barlow DH, O'Brien GT, Last CG. Couples treatment of agoraphobia. Behav Ther. 1984;15:41-58.
115. Cerny JA, Barlow DH, Craske MG, Himadi WG. Couples treatment of agoraphobia: a two-year follow-up. Behav Ther. 1987;18:401-416.
116. Swinson RP, Soulios C, Cox BJ, Kuch K. Brief treatment of emergency room patients with panic attacks. Am J Psychiatry. 1992;149:944-946.
117. Keller MB, Hanks DL. Course and outcome in panic disorder. Prog Neuropsychopharmacol Biol Psychiatry. 1993;17:551-570.